2011
DOI: 10.4172/1948-5956.1000054
|View full text |Cite
|
Sign up to set email alerts
|

HIF-1 is the Commander of Gateways to Cancer

Abstract: The hypoxia-inducible factor-1 (HIF-1) is primarily involved in the sensing and adapting of cells to changes in the O2 level, which is essential for their viability. An increased activity is recognized in the majority of clinical relevant hypoxic/ischemic episodes and human cancers .HIF-1 is considered a central regulator of the adaptation response of cancer cells to hypoxia that makes it a therapeutic target in solid tumors. In this article, the biochemical pathways that are regulated by HIF-1 and the factors… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 41 publications
(34 reference statements)
0
7
0
Order By: Relevance
“…HK is the first glycolytic enzyme that facilitates the irreversible conversion of glucose to glucose-6-phosphate in cells, thereby committing the glucose molecule to the glycolytic cycle. Additionally, HIF-1 has been shown to effectively up-regulate many glycolytic enzymes, leading to enhanced glycolysis activity [50]. The enhanced tumour glycolytic flux triggered by HIF-1a also involves changes in the kinetic patterns of expressed isoforms of key glycolytic enzymes, further improving glycolytic energetic capability [50].…”
Section: Hypoxia Inducible Factor-1 and Metabolismmentioning
confidence: 99%
See 2 more Smart Citations
“…HK is the first glycolytic enzyme that facilitates the irreversible conversion of glucose to glucose-6-phosphate in cells, thereby committing the glucose molecule to the glycolytic cycle. Additionally, HIF-1 has been shown to effectively up-regulate many glycolytic enzymes, leading to enhanced glycolysis activity [50]. The enhanced tumour glycolytic flux triggered by HIF-1a also involves changes in the kinetic patterns of expressed isoforms of key glycolytic enzymes, further improving glycolytic energetic capability [50].…”
Section: Hypoxia Inducible Factor-1 and Metabolismmentioning
confidence: 99%
“…Additionally, HIF-1 has been shown to effectively up-regulate many glycolytic enzymes, leading to enhanced glycolysis activity [50]. The enhanced tumour glycolytic flux triggered by HIF-1a also involves changes in the kinetic patterns of expressed isoforms of key glycolytic enzymes, further improving glycolytic energetic capability [50]. HIF-1 also induces the transcription of pyruvate dehydrogenase kinase 1 (PDK1), which effectively inhibits pyruvate dehydrogenase activity, thereby blocking the conversion of pyruvate the acetyl CoA.…”
Section: Hypoxia Inducible Factor-1 and Metabolismmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, blocking HIF-1α activity is a critical step for inhibiting tumor angiogenesis and growth (Ke and Costa, 2006; Na, 2011). HIF-1 is a heterodimer consisting of an αsubunit and a β subunit.…”
Section: Introductionmentioning
confidence: 99%
“…Hypoxia inducible factor-1 (HIF-1) is a crucial transcription factor that regulates the expression of target genes involved in angiogenesis, growth factor signaling, cancer cell invasion, and metastasis ( Bardos and Ashcroft, 2005 , Choi et al, 2014 ). Therefore, blocking HIF-1α activity is a critical step for inhibiting tumor angiogenesis and growth ( Ke and Costa, 2006 ; Na, 2011 ). HIF-1 is a heterodimer consisting of an αsubunit and a β subunit.…”
Section: Introductionmentioning
confidence: 99%